...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Highly rifampin-resistant Listeria monocytogenes isolated from a patient with prosthetic bone infection
【24h】

Highly rifampin-resistant Listeria monocytogenes isolated from a patient with prosthetic bone infection

机译:从假肢骨感染患者中分离出的高度耐利福平单核细胞增生李斯特菌

获取原文
获取原文并翻译 | 示例
           

摘要

Listeriosis is a rare but severe food-borne infection due to Listeria monocytogenes. L. monocytogenes is naturally susceptible to a wide range of antibiotics, including penicillins, aminoglyco-sides, tetracyclines, macrolides, co-trimoxazole, linezolid, moxi-floxacin, glycopeptides, and rifampin, but not to cephalosporins (1-3). L. monocytogenes resistance to antimicrobials is rare; it was estimated to be around 1.3% in 4,668 clinical isolates tested in the National Reference Centre for Listeria (NRCL) (3), involving mostly resistance to fluoroquinolones but not rifampin (1, 3-5).
机译:李斯特菌病是一种由于李斯特菌引起的罕见但严重的食源性感染。单核细胞增生李斯特氏菌自然易受多种抗生素的影响,包括青霉素,氨基糖苷,四环素,大环内酯,复方新诺明,利奈唑胺,莫西沙星,糖肽和利福平,但对头孢菌素则不敏感(1-3)。单核细胞增生李斯特氏菌对抗菌药的耐药性很罕见;在美国国家李斯特菌参考中心(NRCL)中测试的4668株临床分离株中,估计约占1.3%(3),主要涉及对氟喹诺酮类药物的耐药性,但对利福平没有耐药性(1,3-5)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号